０７６萌ＳＮＳ
  • Login

  • Public

    • Public
    • Network
    • Groups
    • Popular
    • People

Conversation

Notices

  1. Ars Technica (arstechnica@mastodon.social)'s status on Wednesday, 16-Oct-2024 06:56:19 JST Ars Technica Ars Technica

    Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals

    FDA is reviewing its decision to remove tirzepatide drugs from the shortage list.

    https://arstechnica.com/health/2024/10/drugmakers-can-keep-making-off-brand-weight-loss-drugs-as-fda-backpedals/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

    In conversation about a month ago from mastodon.social permalink

    Attachments


    1. https://files.mastodon.social/media_attachments/files/113/313/668/990/225/165/original/859100975b731847.jpg

    Feeds

    • Activity Streams
    • RSS 2.0
    • Atom
    • Help
    • About
    • FAQ
    • TOS
    • Privacy
    • Source
    • Version
    • Contact

    ０７６萌ＳＮＳ is a social network, courtesy of ０７６. It runs on GNU social, version 2.0.2-beta0, available under the GNU Affero General Public License.

    Creative Commons Attribution 3.0 All ０７６萌ＳＮＳ content and data are available under the Creative Commons Attribution 3.0 license.